Moderna has announced its efforts to develop a vaccine for Hantavirus. The biotechnology company, known for its mRNA technology, is expanding its vaccine portfolio to address this virus, which is primarily transmitted to humans through contact with rodent excrement. This initiative marks another step in Moderna's ongoing commitment to tackling infectious diseases through innovative vaccine solutions.